Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Beam Therapeutics Inc
(NQ:
BEAM
)
25.94
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Beam Therapeutics Inc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
3 Stocks Cathie Wood Is Buying That Should Be on Your List, Too
September 22, 2023
Cathie Wood is loading up on these healthcare stocks.
Via
The Motley Fool
2 Cutting-Edge Gene-Editing Stocks That You Don't Want to Miss
September 19, 2023
The gene-editing market is moving fast, and it pays to get to know some of these companies.
Via
The Motley Fool
Here's the 1 Cathie Wood Stock Most Likely to Turn $100,000 Into $1 Million Over the Next 20 Years
September 17, 2023
There's no guarantee that any stock will be a millionaire-maker. But the chances for this one look pretty good.
Via
The Motley Fool
This Cathie Wood Stock Is Down 40% in 2023. Here's Why She's Still Buying It.
September 08, 2023
The decline of Beam's stock says little about its long-term potential, according to Wood.
Via
The Motley Fool
Cathie Wood's Buying These 3 Stocks Hand Over Fist
September 08, 2023
A drugmaker, a gene sequencer, and a streaming business all made deep impressions on Ark Invest's stock-picking team.
Via
The Motley Fool
4 Analysts Have This to Say About Beam Therapeutics
August 29, 2023
Via
Benzinga
2 Supercharged Growth Stocks That Could Make You Richer
July 15, 2023
These two companies could disrupt healthcare on a global scale.
Via
The Motley Fool
Beam Therapeutics: Q1 Earnings Insights
May 10, 2023
Via
Benzinga
Beam Therapeutics Presents Preclinical Data Highlighting Utility of BEAM-302 to Correct an Alpha-1 Antitrypsin (AAT) Deficiency Disease-Causing Mutation
September 07, 2023
First Preclinical Data for BEAM-302 Demonstrate Increased Levels of Corrected AAT and Reduced Mutant PiZ AAT in Multiple In Vivo Rodent Disease Models
From
Beam Therapeutics
Via
GlobeNewswire
Cathie Wood's Ark Invest Keeps Shedding Shopify Nvidia Shares, Loads Up On Spotify Stock
September 05, 2023
Via
Benzinga
Beam Therapeutics' Role In Gene-Editing 2.0 Revolution: First U.S. Patient Treated With Base-Edited Cell Therapy
September 05, 2023
Beam Therapeutics Inc (NASDAQ: BEAM) announced that in August, the first patient was treated with BEAM-201, a quadruplex-edited allogeneic
Via
Benzinga
Beam Therapeutics Announces First Patient Dosed in Phase 1/2 Trial of BEAM-201 in Relapsed, Refractory T-ALL/T-LL
September 05, 2023
BEAM-201 Represents First Quadruplex-edited, Allogeneic CAR-T Cell Therapy Candidate in Clinical-stage Development and First Treatment with a Base Editing Candidate in United States
From
Beam Therapeutics
Via
GlobeNewswire
Beam Therapeutics to Participate in Upcoming September Investor Conferences
August 31, 2023
From
Beam Therapeutics
Via
GlobeNewswire
Why Is Apellis Pharmaceuticals Stock Trading Lower Today?
August 29, 2023
Apellis Pharmaceuticals Inc (NASDAQ: APLS) revealed a comprehensive corporate restructuring plan aimed at catalyzing the growth of its flagship products, Syfovre (pegcetacoplan injection) and
Via
Benzinga
3 Cathie Wood Stocks With Parabolic Growth Potential, According to Wall Street
August 26, 2023
These cutting-edge biotech stocks could deliver life-changing gains for early shareholders.
Via
The Motley Fool
Got $200? 3 Growth Stocks to Buy That Could Double Your Money
August 19, 2023
There's no guarantee that any stock will deliver 2 times returns. But the chances for these stocks look pretty good.
Via
The Motley Fool
Cathie Wood's Ark Invest Sells More Tesla Stock — Acquires Shares Of Flying Taxi Company
August 15, 2023
Via
Benzinga
Cathie Wood's Ark Invest Sells $2.15M Of Tesla Shares Despite Own Bullish Projections
August 14, 2023
Via
Benzinga
Credit Suisse Maintains Neutral Rating for Beam Therapeutics: Here's What You Need To Know
August 09, 2023
Via
Benzinga
Beam Therapeutics Reports Pipeline Updates and Second Quarter 2023 Financial Results
August 08, 2023
From
Beam Therapeutics
Via
GlobeNewswire
3 Pharma Stocks That AI is Loving in July
July 13, 2023
Artificial intelligence recommends that these are the three stocks to consider when investing in pharma stocks.
Via
InvestorPlace
Verve Therapeutics Gains 20.74% In June as Ark Funds Invest
June 30, 2023
Verve Therapeutics' efforts to eliminate cardiovascular disease through gene-editing treatments have momentum, as the stock gets a 20.74% boost in June.
Via
MarketBeat
Here's the Secret Behind Cathie Wood's Latest Moneymaking Strategy
June 18, 2023
Success could be in the DNA of the Ark Invest founder.
Via
The Motley Fool
Cathie Wood Is Buying This Biotech Stock Like Wildfire, But Should You?
May 21, 2023
It's facing a few issues that are practically guaranteed to affect shareholder returns.
Via
The Motley Fool
Beam Therapeutics to Participate in Upcoming May Investor Conferences
May 17, 2023
From
Beam Therapeutics
Via
GlobeNewswire
Cathie Wood Is Loading Up on These 3 Stocks Down 70% or More. Should You?
May 16, 2023
The Ark Invest CEO is betting on rebounds for these beaten-down stocks.
Via
The Motley Fool
Beam Therapeutics to Participate in RBC Capital Markets 2023 Global Healthcare Conference
May 11, 2023
From
Beam Therapeutics
Via
GlobeNewswire
Beam Therapeutics Reports Pipeline Updates and First Quarter 2023 Financial Results
May 10, 2023
From
Beam Therapeutics
Via
GlobeNewswire
7 Best Cathie Wood Stocks for Your May 2023 Buy List
May 02, 2023
This year promises to be very different for Cathie Wood stocks, as signs of economic improvement become more prominent.
Via
InvestorPlace
3 Growth Stocks Cathie Wood Just Bought That Could Be Absolute Game-Changers
May 02, 2023
Cathie Wood is loading up on these biotech stocks.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.